美国 · SEC FORM 4
STANDARD BIOTOOLS INC.
LAB · Nasdaq · CIK 0001162194 · Healthcare · Medical Devices
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
15 同一窗口内观察到的 Form 4 交易行
0 sales · 15 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-12-04 · CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. · $217.5K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Mackay SeanSVP & Chief Business Officer
○○○
Kim Hanjoon AlexChief Financial Officer
○○○
Egholm MichaelPresident & CEO
○○○
Witney FrankDirector
○
HIBBS KATHY LDirector
○
ELOI FENEL MDirector
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 3 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-12-04 · CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P..
近期 Form 4 活动
15买入
0卖出
28其他 Form 4 交易行
31SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他15 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,520,686
- 上期报告
- 2,593,308
- 日均成交量
- 925,491
- 回补天数
- 2.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 150,000 | USD 1.45 | USD 217,500 | SEC 申报 ↗ |
| 2025-12-03 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 75,000 | USD 1.44 | USD 108,000 | SEC 申报 ↗ |
| 2025-12-02 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 125,000 | USD 1.42 | USD 177,500 | SEC 申报 ↗ |
| 2025-11-25 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 7,550,000 | USD 1.30 | USD 9,815,000 | SEC 申报 ↗ |
| 2025-11-24 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 150,000 | USD 1.43 | USD 214,500 | SEC 申报 ↗ |
| 2025-11-20 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 450,000 | USD 1.30 | USD 585,000 | SEC 申报 ↗ |
| 2025-11-19 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 350,000 | USD 1.28 | USD 448,000 | SEC 申报 ↗ |
| 2025-11-18 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 275,000 | USD 1.23 | USD 338,250 | SEC 申报 ↗ |
| 2025-11-17 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 225,000 | USD 1.22 | USD 274,500 | SEC 申报 ↗ |
| 2025-11-14 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 250,000 | USD 1.24 | USD 310,000 | SEC 申报 ↗ |
| 2025-11-13 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 450,000 | USD 1.20 | USD 540,000 | SEC 申报 ↗ |
| 2025-11-12 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 375,000 | USD 1.19 | USD 446,250 | SEC 申报 ↗ |
| 2025-11-11 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 300,000 | USD 1.20 | USD 360,000 | SEC 申报 ↗ |
| 2025-11-10 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 275,000 | USD 1.17 | USD 321,750 | SEC 申报 ↗ |
| 2025-11-07 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 225,000 | USD 1.12 | USD 252,000 | SEC 申报 ↗ |
Form 4 申报证据
43 transaction lines in the latest 365-day window; 420 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Mackay Sean | 代扣税 (F) | Common Stock | 25,729 | USD 0.67 | USD 17,238 | SEC 申报 ↗ |
| 2026-08-20 | Kim Hanjoon Alex | 代扣税 (F) | Common Stock | 28,195 | USD 0.67 | USD 18,891 | SEC 申报 ↗ |
| 2026-08-20 | Egholm Michael | 代扣税 (F) | Common Stock | 97,627 | USD 0.67 | USD 65,410 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Mackay Sean | 代扣税 (F) | Common Stock | 25,729 | USD 0.67 | USD 17,238 | SEC 申报 ↗ |
| 2026-08-20 | Kim Hanjoon Alex | 代扣税 (F) | Common Stock | 28,195 | USD 0.67 | USD 18,891 | SEC 申报 ↗ |
| 2026-08-20 | Egholm Michael | 代扣税 (F) | Common Stock | 97,627 | USD 0.67 | USD 65,410 | SEC 申报 ↗ |
| 2026-08-03 | Egholm Michael | 代扣税 (F) | Common Stock | 362,625 | USD 0.87 | USD 315,484 | SEC 申报 ↗ |
| 2026-07-23 | Kim Hanjoon Alex | 代扣税 (F) | Common Stock | 202,476 | USD 0.90 | USD 182,228 | SEC 申报 ↗ |
| 2026-06-20 | Mackay Sean | 奖励／授予 (A) | Common Stock | 500,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Witney Frank | 奖励／授予 (A) | Common Stock | 99,116 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | HIBBS KATHY L | 奖励／授予 (A) | Common Stock | 99,116 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | ELOI FENEL M | 奖励／授予 (A) | Common Stock | 99,116 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Cox Troy | 奖励／授予 (A) | Common Stock | 99,116 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Casdin Eli | 奖励／授予 (A) | Common Stock | 99,116 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Carey Thomas D. | 奖励／授予 (A) | Common Stock | 99,116 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Mackay Sean | 代扣税 (F) | Common Stock | 25,729 | USD 1.00 | USD 25,729 | SEC 申报 ↗ |
| 2026-05-20 | Kim Hanjoon Alex | 代扣税 (F) | Common Stock | 18,871 | USD 1.00 | USD 18,871 | SEC 申报 ↗ |
| 2026-05-20 | Egholm Michael | 代扣税 (F) | Common Stock | 97,626 | USD 1.00 | USD 97,626 | SEC 申报 ↗ |
| 2026-04-06 | Kim Hanjoon Alex | 期权行权／转换 (M) | Common Stock | 70,183 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-06 | Kim Hanjoon Alex | 代扣税 (F) | Common Stock | 21,301 | USD 0.91 | USD 19,384 | SEC 申报 ↗ |
| 2026-04-06 | Egholm Michael | 期权行权／转换 (M) | Common Stock | 196,513 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-06 | Egholm Michael | 代扣税 (F) | Common Stock | 95,014 | USD 0.91 | USD 86,463 | SEC 申报 ↗ |
| 2026-02-26 | Cox Troy | 奖励／授予 (A) | Common Stock | 57,264 | USD 1.17 | USD 66,999 | SEC 申报 ↗ |
| 2026-02-26 | Casdin Eli | 奖励／授予 (A) | Common Stock | 52,991 | USD 1.17 | USD 61,999 | SEC 申报 ↗ |
| 2026-02-26 | Carey Thomas D. | 奖励／授予 (A) | Common Stock | 51,282 | USD 1.17 | USD 60,000 | SEC 申报 ↗ |
| 2026-02-23 | Mackay Sean | 代扣税 (F) | Common Stock | 19,661 | USD 1.15 | USD 22,610 | SEC 申报 ↗ |
| 2026-02-23 | Kim Hanjoon Alex | 代扣税 (F) | Common Stock | 12,740 | USD 1.15 | USD 14,651 | SEC 申报 ↗ |
| 2026-02-23 | Egholm Michael | 代扣税 (F) | Common Stock | 66,127 | USD 1.15 | USD 76,046 | SEC 申报 ↗ |
| 2025-12-04 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 150,000 | USD 1.45 | USD 217,500 | SEC 申报 ↗ |
| 2025-12-03 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 75,000 | USD 1.44 | USD 108,000 | SEC 申报 ↗ |
| 2025-12-02 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 125,000 | USD 1.42 | USD 177,500 | SEC 申报 ↗ |
| 2025-11-25 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 7,550,000 | USD 1.30 | USD 9,815,000 | SEC 申报 ↗ |
| 2025-11-24 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC; Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P.; Casdin Private Growth Equity Fund II GP, LLC; Casdin Private Growth Equity Fund II, L.P.; Casdin Private Growth Equity Fund, L.P. | 买入 (P) | Common Stock, $0.001 par value per share | 150,000 | USD 1.43 | USD 214,500 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LAB |
| CIK | 0001162194 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 420 transaction lines from 2020-02-04 to 2026-08-20 79 P purchase lines · 10 S sale lines · 331 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.